Raimondi, Raffaele
Sow, Karmen
Peto, Tunde
Wride, Nicholas
Habib, Maged S.
Sproule, Alan
Muldrew, Alyson K.
Quinn, Michael
Steel, David H.
Funding for this research was provided by:
Alcon
Boehringer Ingelheim
Bayer
Roche
BVI
DORC
Boehringer Ingelheim
Alimera
Article History
Received: 17 December 2024
Revised: 26 March 2025
Accepted: 21 April 2025
First Online: 29 April 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutions where the study was carried out and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. UK multicenter ethical approval (London—Camden & Kings Cross Research Ethics Committee reference:21/LO/0067). Informed consent was obtained from all individual participants included in the study.
: R. Raimondi, K. Sow, T. Peto, N. Wride, A. Sproule, A. Muldrew, M. Quinn certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.